How Much Does Trelegy Ellipta Cost?

Our most recent US pharmacy data shows a low of roughly $554.10 for Trelegy Ellipta with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

We found Canadian pricing for Trelegy Ellipta starting near $1.56 per tablet in USD terms. That's before any shipping charge, which the table above breaks out separately.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. Check the comparison table above for the specific numbers on Trelegy Ellipta.

Generic and brand-name pricing for Trelegy Ellipta is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

No, there is currently no generic (bioequivalent) version of Trelegy Ellipta approved for use in the United States. Based on current patent protections, a generic alternative is not expected to become available until around 2030.

If the cost of Trelegy Ellipta is a concern, several strategies may help lower your out-of-pocket expenses. These include: using a free pharmacy savings card; asking your doctor about the possibility of free samples (though this is a short-term solution); checking if you qualify for a manufacturer's coupon program; applying for patient assistance programs based on income eligibility; comparing prices at different local pharmacies; enrolling in Medicare Extra Help if you are eligible; using funds from a Flexible Spending Account (FSA) or Health Savings Account (HSA); and discussing with your healthcare provider whether a clinically appropriate, lower-cost alternative medication is an option for you.

The availability and cost of alternative medications depend heavily on your insurance formulary and your specific diagnosis. For COPD, Breztri Aerosphere is another triple-therapy inhaler, but it is not approved for asthma. Other inhalers for COPD that contain two of Trelegy's three drug components include Bevespi Aerosphere, Anoro Ellipta, and Stiolto Respimat. For asthma, there are numerous other treatment classes to consider. It is essential to consult with your doctor or pharmacist to review all suitable options and determine the most effective and affordable treatment plan for your condition.